Related Experiment Video
Updated: Mar 15, 2026

Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
Improved Cardiometabolic Health with Uterine-Preserving Fibroid Treatment Compared to Hysterectomy
Rachel Michel1,2, Gregory W Kirschen3, Caitlin S Stukel2
1Department of Gynecology & Obstetrics, Johns Hopkins University, Baltimore, MD 21287, USA.
Insights
Hysterectomy for uterine fibroids increases the risk of cardiometabolic disorders like stroke and type II diabetes compared to myomectomy or no surgery. Ovarian retention did not alter these adverse outcomes.
Area of Science:
- Cardiovascular Science
- Gynecologic Surgery
- Metabolic Health
Background:
- Hysterectomy is a common procedure in the U.S., often indicated for uterine fibroids.
- The association between hysterectomy and long-term cardiometabolic health remains unclear.
- This study investigates cardiometabolic outcomes following hysterectomy for uterine fibroids.
Purpose of the Study:
- To determine if hysterectomy is linked to adverse cardiometabolic outcomes in patients with uterine fibroids.
- To compare outcomes between hysterectomy, myomectomy, and no surgical intervention.
Main Methods:
- Retrospective cohort study using U.S. healthcare claims data (MarketScan®).
- Included patients aged 18-55 diagnosed with uterine fibroids between 2010-2011.
- Followed 34,722 participants for 10 years, stratifying into hysterectomy, myomectomy, or no surgery groups.
Main Results:
- Hysterectomy (n=8,196) was associated with increased odds of stroke, hypertension, hyperlipidemia, and type II diabetes versus no surgery (n=25,175).
- Hysterectomy showed higher odds of hyperlipidemia compared to myomectomy (n=1,351).
- Cardiometabolic outcomes were similar whether ovaries were removed or retained during hysterectomy.
Conclusions:
- Hysterectomy for uterine fibroids is associated with a higher risk of adverse cardiometabolic outcomes.
- Myomectomy or no surgery may be preferable for preserving long-term cardiometabolic health.
- Ovarian retention does not mitigate the cardiometabolic risks associated with hysterectomy.
Abstract:
Background/Objectives: Over 600,000 hysterectomies are performed in the United States annually, with uterine fibroids being the most common indication. It remains unknown whether removal of the uterus is associated with poor cardiometabolic outcomes. This study aimed to determine whether hysterectomy is associated with adverse cardiometabolic outcomes among patients with uterine fibroids (myomectomy and no surgery as controls). Methods: Retrospective cohort study utilizing MarketScan® Database of U.S. healthcare claims dataset, including patients aged 18-55 with uterine fibroid diagnosis in 2010 or 2011 and 10 years of continuous enrollment. Patients were stratified into three groups: hysterectomy, myomectomy, and no surgery. Patients were then followed for 10 years to determine incidence of cardiometabolic disorders. The main outcome measures included coronary artery disease, congestive heart failure, cardiac arrhythmia, stroke, hypertension, hyperlipidemia, type II diabetes, and peripheral artery disease, which were defined using the ICD-9, ICD-10, and CPT codes. Results: 34,722 participants with uterine fibroids were identified. Among these, 8,196 (23.61%) patients underwent hysterectomy, 1351 patients (3.89%) underwent myomectomy, and 25,175 (72.50%) patients did not undergo surgery. Hysterectomy was associated with higher age-adjusted odds of developing stroke (aOR = 1.11), hypertension (aOR = 1.14), hyperlipidemia (aOR = 1.14), and type II diabetes (aOR = 1.20) compared to no surgery. Hysterectomy was associated with higher age-adjusted odds of developing hyperlipidemia (aOR = 1.26) compared to myomectomy. Hysterectomy with removal of ovaries versus hysterectomy with retention of ovaries had similar cardiometabolic outcomes. Conclusions: Among patients with fibroids, hysterectomy was associated with higher odds of developing adverse cardiometabolic outcomes compared to myomectomy or no surgery. Retention of the ovaries was not protective among those undergoing hysterectomy.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management

